Systemic effect of human growth hormone after intramuscular injection of a single dose of a muscle-specific gene medicine

Human Gene Therapy

Volumn 9, Issue 5, 1998, Pages 659-670

  Anwer, Khursheed ^a   Shi, Mei ^a   French, Martha F ^a   Muller, Susanne R ^a   Chen, Wei ^a   Liu, Qingsong ^a   Proctor, Belinda L ^a   Wang, Jijun ^a   Mumper, Russell J ^a   Singhal, Arun ^a   Rolland, Alain P ^a   Alila, Hector W ^a  

^a GeneMedicine Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; CYCLOSPORIN; HUMAN GROWTH HORMONE; POVIDONE; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BLOOD LEVEL; CHICKEN; CONTROLLED STUDY; ENHANCER REGION; GENE EXPRESSION SYSTEM; GENE THERAPY; GENETIC TRANSFECTION; GROWTH; HORMONE SYNTHESIS; HYPOPHYSECTOMY; INTRAMUSCULAR DRUG ADMINISTRATION; INTRATRACHEAL DRUG ADMINISTRATION; MALE; MUSCLE; MYOBLAST; NONHUMAN; PLASMID; PROMOTER REGION; RAT;

ANIMALIA; GALLUS GALLUS;

EID: 2642690755     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.5-659     Document Type: Article

References (11)

1. ALILA, H., COLEMAN, M., NITTA, H., FRENCH, M., ANWER, K., LIU, Q., MEYER, T., WANG, J., MUMPER, R.J., OUBARI, D., LONG, S., NORDSTROM, J., and ROLLAND, A.P. (1997). Expression of a biologically active human Insulin-like growth factor-1 following intramuscular injection of a formulated plasmid in rats. Hum. Gene. Ther. 8, 1785-1795.
2. ANSON, D.S., AUSTEN, D.E., and BROWNLEE, G.G. (1985). The gene structure of human anti-haemophiliac factor IX. Nature 315, 683-685.
3. BATES, P.C., ASTON, R., and HOLDER, A.T. (1992). Growth hormone control of tissue protein metabolism in dwarf mice: enhancement by monoclonal antibody. J. Endocrinol. 132, 369-375.
4. BERGSMA, D.J., GRICHNIK, J.M., GOSSETT, L.M., and SCHWARTZ, R.J. (1986). Delimitation and characterization of cisacting DNA sequences required for the regulated expression and transcriptional control of the chicken skeletal α-actin gene. Mol. Cell Biol. 6, 2462-2475.
5. BRENNAN, K.J., and HARDEMAN, E.G. (1993). Quantitative analysis of the human α-skeletal actin gene in transgenic mice. J. Biol. Chem. 268, 719-725.
6. BROOK, J.D., McCURRACH, M.E., HARLEY, H.G., BUCKLER, A.J., CHURCH, D., ABURATON, H., HUNTER, K., STANTON, V.P., THIRION, J., and HUDSON, T. (1992). Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68, 799-808.
7. COLEMAN, M.E., DEMAYO, F., YEN, K.C., LEE, H.M., GESKE, R., MONTGOMERY, C., and SCHWARTZ, J.R. (1995). Myogenic vector expression of insulin-like growth factor-I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J. Biol. Chem. 270, 12109-12116.
8. DAI, Y., ROMAN, M., NAVIAUX, R.K., and VERMA, I.M. (1992). Gene therapy via primary myoblasts: Long-term expression of factor IX protein following transplantation in vivo. Proc. Natl. Acad. Sci. USA 89, 10892-10895.
9. DAVIS, H., MICHAEL, M.L., MANCINI, M., SCHLEEF, M., and WAHLEN, R.G. (1994). Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B surface antigen. Vaccine 12, 1503-1509.
10. MOSLEY, A.B., and CASKEY, C.T. (1993). Human genetic disease and the medical need for somatic gene therapy. Adv. Drug. Deliv. Rev. 12, 131-142.
11. MUMPER, R.J., DUGUID, J.G., ANWER, K., BARRON, M.K., NITTA, H., and ROLLAND, A.P. (1996). Polyvinyl derivatives as novel interactive polymers for controlled gene delivery to muscle. Pharmacol. Res. 13, 701-709.